| 1 |
32393046 |
10.1080/09603123.2020.1757043 |
2022 |
The expression of microRNAs and exposure to environmental contaminants related to human health: a review. |
BCL6 |
| 2 |
33779481 |
10.1080/01676830.2021.1904426 |
2022 |
Double-hit and triple-hit high-grade B-cell lymphoma of the ocular adnexa. |
BCL6 |
| 3 |
34180720 |
10.1177/10668969211027409 |
2022 |
Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report. |
BCL6 |
| 4 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
BCL6 |
| 5 |
34392269 |
10.1097/PAS.0000000000001750 |
2022 |
Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity. |
BCL6 |
| 6 |
34456240 |
10.1097/PAI.0000000000000967 |
2022 |
Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting. |
BCL6 |
| 7 |
34519021 |
10.1111/bjh.17815 |
2022 |
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. |
BCL6 |
| 8 |
34601504 |
10.1038/s41379-021-00938-z |
2022 |
Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. |
BCL6 |
| 9 |
34608246 |
10.1038/s41379-021-00909-4 |
2022 |
Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. |
BCL6 |
| 10 |
34617271 |
10.1111/bjh.17874 |
2022 |
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. |
BCL6 |
| 11 |
34637146 |
10.1111/his.14585 |
2022 |
EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study. |
BCL6 |
| 12 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
BCL6 |
| 13 |
34707034 |
10.3960/jslrt.21017 |
2022 |
Clinicopathological analysis of diffuse large B-cell lymphoma lacking surface immunoglobulin light chain restriction on flow cytometry. |
BCL6 |
| 14 |
34727403 |
10.1111/pin.13182 |
2022 |
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. |
BCL6 |
| 15 |
34727830 |
10.1080/10428194.2021.1998480 |
2022 |
Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma. |
BCL6 |
| 16 |
34774129 |
10.1016/j.str.2021.10.010 |
2022 |
Structural basis of Apt48 inhibition of the BCL6 BTB domain. |
BCL6 |
| 17 |
34788750 |
10.1159/000519074 |
2022 |
Application of Hans Algorithm for Subcategorization of Diffuse Large B-Cell Lymphoma in Fine-Needle Aspiration Biopsy Cytology. |
BCL6 |
| 18 |
34788985 |
10.3324/haematol.2021.279631 |
2022 |
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing. |
BCL6 |
| 19 |
34809978 |
10.1016/j.fertnstert.2021.09.036 |
2022 |
B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population. |
BCL6 |
| 20 |
34842019 |
10.1080/10428194.2021.2008383 |
2022 |
Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole? |
BCL6 |
| 21 |
34861697 |
10.1182/bloodadvances.2021006156 |
2022 |
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo. |
BCL6 |
| 22 |
34907996 |
10.1097/PAS.0000000000001852 |
2022 |
Human Germinal Center-associated Lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell Lymphoma. |
BCL6 |
| 23 |
34910327 |
10.1111/jop.13269 |
2022 |
Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases. |
BCL6 |
| 24 |
34917911 |
10.1016/j.jhepr.2021.100386 |
2022 |
ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. |
BCL6 |
| 25 |
34951009 |
10.1111/bjh.17971 |
2022 |
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. |
BCL6 |
| 26 |
34990752 |
10.1016/j.canlet.2021.12.035 |
2022 |
An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. |
BCL6 |
| 27 |
35036912 |
10.1177/2632010X211070774 |
2022 |
Rare but Potentially Fatal Presentations of Diffuse Large B-cell Lymphoma: Leukemic Phase or Hemophagocytic Syndrome in Bone Marrow. |
BCL6 |
| 28 |
35045798 |
10.1080/10428194.2021.2024821 |
2022 |
High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma. |
BCL6 |
| 29 |
35046056 |
10.1158/1078-0432.CCR-21-3617 |
2022 |
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. |
BCL6 |
| 30 |
35067515 |
10.1097/PAS.0000000000001828 |
2022 |
Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. |
BCL6 |
| 31 |
35091546 |
10.1038/s41420-022-00833-9 |
2022 |
Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. |
BCL6 |
| 32 |
35152630 |
10.3760/cma.j.cn112151-20210826-00604 |
2022 |
[Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements]. |
BCL6 |
| 33 |
35183824 |
10.1016/j.prp.2022.153804 |
2022 |
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma. |
BCL6 |
| 34 |
35220171 |
10.1016/j.prp.2022.153812 |
2022 |
Prognostic value of Bcl2 and Bcl6 in primary cutaneous large B-cell lymphoma: A systematic review and meta-analysis. |
BCL6 |
| 35 |
35256863 |
10.2147/CMAR.S345745 |
2022 |
MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP. |
BCL6 |
| 36 |
35297566 |
10.1111/pin.13223 |
2022 |
Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements. |
BCL6 |
| 37 |
35303910 |
10.1186/s13045-022-01249-9 |
2022 |
Altered pathways and targeted therapy in double hit lymphoma. |
BCL6 |
| 38 |
35308723 |
10.7759/cureus.22023 |
2022 |
Conjunctival Pediatric-Type Follicular Lymphoma in a Young Male: A Case Report and Literature Review. |
BCL6 |
| 39 |
35327381 |
10.3390/biomedicines10030579 |
2022 |
Macrophage Infiltration Correlates with Genomic Instability in Classic Hodgkin Lymphoma. |
BCL6 |
| 40 |
35357654 |
10.1007/s13402-022-00663-y |
2022 |
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer. |
BCL6 |
| 41 |
35371331 |
10.7150/jca.69639 |
2022 |
Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma. |
BCL6 |
| 42 |
35414839 |
NA |
2022 |
Primary ovarian Burkitt lymphoma: report of a case and review of literature. |
BCL6 |
| 43 |
35436984 |
10.1038/s41419-022-04812-x |
2022 |
B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. |
BCL6 |
| 44 |
35444774 |
10.4084/MJHID.2022.018 |
2022 |
TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment. |
BCL6 |
| 45 |
35481444 |
10.1080/10428194.2022.2064988 |
2022 |
Impact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation. |
BCL6 |
| 46 |
35484682 |
10.3324/haematol.2021.280557 |
2022 |
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement. |
BCL6 |
| 47 |
35489963 |
10.1016/j.blre.2022.100967 |
2022 |
ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma. |
BCL6 |
| 48 |
35495111 |
10.1016/j.csbj.2022.03.023 |
2022 |
Integrating whole genome sequencing, methylation, gene expression, topological associated domain information in regulatory mutation prediction: A study of follicular lymphoma. |
BCL6 |
| 49 |
35503721 |
10.7554/eLife.69255 |
2022 |
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress. |
BCL6 |
| 50 |
35511691 |
10.1093/ajcp/aqac047 |
2022 |
A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma. |
BCL6 |
| 51 |
35521914 |
10.1177/10668969221099627 |
2022 |
ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype. |
BCL6 |
| 52 |
35539018 |
10.1016/j.lrr.2022.100318 |
2022 |
A very rare case of extranodal B-cell non-Hodgkin lymphoma presenting with adrenal and heart involvement. |
BCL6 |
| 53 |
35568724 |
10.1038/s41394-022-00520-y |
2022 |
Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report. |
BCL6 |
| 54 |
35583405 |
10.1097/DAD.0000000000002053 |
2022 |
Histological Transformation and Clonal Relationship of Subcutaneous Marginal Zone B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma. |
BCL6 |
| 55 |
35600178 |
10.1016/j.amsu.2022.103786 |
2022 |
Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study. |
BCL6 |
| 56 |
35607925 |
10.17235/reed.2022.8765/2022 |
2022 |
Intestinal occlusion due to Burkitt lymphoma: an unusual cause. |
BCL6 |
| 57 |
35640966 |
10.1093/humupd/dmac027 |
2022 |
BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis. |
BCL6 |
| 58 |
35646671 |
10.3389/fonc.2022.883141 |
2022 |
Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature. |
BCL6 |
| 59 |
35652622 |
10.4149/neo_2022_220318N300 |
2022 |
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry. |
BCL6 |
| 60 |
35653645 |
10.1021/acs.jmedchem.1c02175 |
2022 |
Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 <i>In Vivo</i>. |
BCL6 |
| 61 |
35657291 |
10.1021/acs.jmedchem.1c02174 |
2022 |
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors. |
BCL6 |
| 62 |
35657404 |
10.1007/s00428-022-03342-3 |
2022 |
Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma. |
BCL6 |
| 63 |
35664405 |
10.7759/cureus.24592 |
2022 |
Primary Endometrial Diffuse Large B-cell Lymphoma: A Rare Disease and Diagnostic Challenge in an Asymptomatic Postmenopausal Woman. |
BCL6 |
| 64 |
35696785 |
10.1016/j.biomaterials.2022.121607 |
2022 |
Double-drug loading upconversion nanoparticles for monitoring and therapy of a MYC/BCL6-positive double-hit diffuse large B-cell lymphoma. |
BCL6 |
| 65 |
35705274 |
10.2169/internalmedicine.9711-22 |
2022 |
Biclonal diffuse large B-cell lymphoma commonly characterized by partial trisomy 18q involving MALT1 and BCL2. |
BCL6 |
| 66 |
35713502 |
10.1093/rheumatology/keac304 |
2022 |
TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome. |
BCL6 |
| 67 |
35715938 |
10.1002/cjp2.283 |
2022 |
Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit/triple-hit genotype and survival in diffuse large B-cell lymphoma. |
BCL6 |
| 68 |
35794478 |
10.1038/s41586-022-04906-8 |
2022 |
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. |
BCL6 |
| 69 |
35846201 |
10.1002/jha2.310 |
2022 |
Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report. |
BCL6 |
| 70 |
35869021 |
10.1016/j.clml.2022.06.011 |
2022 |
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements. |
BCL6 |
| 71 |
35873103 |
NA |
2022 |
Neoplasms of follicular helper T-cells: an insight into the pathobiology. |
BCL6 |
| 72 |
35883106 |
10.1186/s12935-022-02661-4 |
2022 |
DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways. |
BCL6 |
| 73 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
BCL6 |
| 74 |
35916066 |
10.1111/imcb.12578 |
2022 |
CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy. |
BCL6 |
| 75 |
35916333 |
10.1002/dc.25027 |
2022 |
HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review. |
BCL6 |
| 76 |
35916644 |
10.1097/QAI.0000000000003069 |
2022 |
Diffuse Large B-cell Lymphoma in the public-sector of Johannesburg, South Africa, in the era of widescale Anti-retroviral therapy use. |
BCL6 |
| 77 |
35932211 |
10.1002/hon.3061 |
2022 |
Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification. |
BCL6 |
| 78 |
35938041 |
10.3389/fgene.2022.940513 |
2022 |
Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma. |
BCL6 |
| 79 |
35957990 |
10.3389/fphys.2022.946282 |
2022 |
Molecular mechanism of hyperactive tooth root formation in oculo-facio-cardio-dental syndrome. |
BCL6 |
| 80 |
35968590 |
10.3760/cma.j.issn.0253-2727.2022.06.006 |
2022 |
[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]. |
BCL6 |
| 81 |
35982974 |
10.3389/fonc.2022.822805 |
2022 |
iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma. |
BCL6 |
| 82 |
35997599 |
10.1089/vim.2021.0224 |
2022 |
Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity. |
BCL6 |
| 83 |
36001789 |
10.46883/2022.25920970 |
2022 |
Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas. |
BCL6 |
| 84 |
36057749 |
10.1007/s00428-022-03404-6 |
2022 |
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma. |
BCL6 |
| 85 |
36091937 |
10.3389/pore.2022.1610588 |
2022 |
Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature. |
BCL6 |
| 86 |
32590454 |
10.1097/PAI.0000000000000863 |
2021 |
Aberrant Cytoplasmic Terminal Deoxynucleotidyl Transferase (TdT) Immunostaining on Previously Frozen, Formalin-fixed Paraffin-embedded Tissue: Cryotomy-induced Antigen Diffusion (CIAD). |
BCL6 |
| 87 |
32675470 |
10.1097/DAD.0000000000001737 |
2021 |
Atypical BCL6/GATA3+ Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma: A Diagnostic Challenge. |
BCL6 |
| 88 |
32731312 |
10.1111/odi.13578 |
2021 |
Clinicopathological and genetic characteristics of diffuse large B-cell lymphoma of the oropharyngeal and maxillofacial region. |
BCL6 |
| 89 |
32863365 |
10.2169/internalmedicine.5429-20 |
2021 |
Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass. |
BCL6 |
| 90 |
32911532 |
10.1182/blood.2019001745 |
2021 |
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells. |
BCL6 |
| 91 |
32911592 |
10.12701/yujm.2020.00675 |
2021 |
Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma. |
BCL6 |
| 92 |
32912960 |
10.1136/jclinpath-2020-206767 |
2021 |
<i>BCL2</i> and <i>BCL6</i> atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course. |
BCL6 |
| 93 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
BCL6 |
| 94 |
32973328 |
10.1038/s41379-020-00685-7 |
2021 |
The clinicopathological and molecular features of sinusoidal large B-cell lymphoma. |
BCL6 |
| 95 |
32979280 |
10.1002/hon.2811 |
2021 |
Hematopoietic stem cell transplantation for diffuse large B-cell lymphoma having 8q24/MYC rearrangement in Japan. |
BCL6 |
| 96 |
33040061 |
10.1159/000509923 |
2021 |
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry. |
BCL6 |
| 97 |
33120427 |
10.1182/blood.2020007193 |
2021 |
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC. |
BCL6 |
| 98 |
33136585 |
10.1097/PAS.0000000000001609 |
2021 |
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. |
BCL6 |
| 99 |
33150819 |
10.1080/08880018.2020.1838013 |
2021 |
<i>KMT2A</i>-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization. |
BCL6 |
| 100 |
33199235 |
10.1016/j.intimp.2020.107137 |
2021 |
Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice. |
BCL6 |
Datasets
Models
